MIST Financial Statements

Balance sheet, income statement, cash flow, and dividends for Milestone Pharmaceuticals Inc (MIST).


$125.85M Market Cap.

As of 03/13/2025 5:00 PM ET (MRY) • Disclaimer

MIST Market Cap. (MRY)


MIST Shares Outstanding (MRY)


MIST Assets (MRY)


Total Assets

$75.50M

Total Liabilities

$62.35M

Total Investments

$44.38M

MIST Income (MRY)


Revenue

$0

Net Income

-$41.52M

Operating Expense

$42.10M

MIST Cash Flow (MRY)


CF Operations

-$28.85M

CF Investing

$8.28M

CF Financing

$32.12M

MIST Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

MIST Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$75,499,000 (0.36%)

$75,226,000 (1.00%)

$74,483,000 (-37.85%)

$119,849,000 (-20.09%)

Assets Current

$73,926,000 (1.22%)

$73,032,000 (1.71%)

$71,803,000 (-39.62%)

$118,923,000 (-20.02%)

Assets Non-Current

$1,573,000 (-28.30%)

$2,194,000 (-18.13%)

$2,680,000 (189.42%)

$926,000 (-28.11%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$13,147,000 (-21.61%)

$16,771,000 (-74.72%)

$66,348,000 (-41.08%)

$112,600,000 (-21.32%)

Property Plant & Equipment Net

$1,573,000 (-28.30%)

$2,194,000 (-18.13%)

$2,680,000 (189.42%)

$926,000 (-28.11%)

Cash & Equivalents

$25,314,000 (83.97%)

$13,760,000 (80.20%)

$7,636,000 (-93.31%)

$114,141,000 (57.85%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$44,381,000 (-15.05%)

$52,243,000 (-8.26%)

$56,949,000 (0%)

$0 (0%)

Investments Current

$44,381,000 (-15.05%)

$52,243,000 (-8.26%)

$56,949,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$1,490,000 (-53.55%)

$3,208,000 (263.72%)

$882,000 (594.49%)

$127,000 (-43.05%)

Trade & Non-Trade Payables

$7,555,000 (13.10%)

$6,680,000 (18.36%)

$5,644,000 (-13.85%)

$6,551,000 (10.77%)

Accumulated Retained Earnings (Deficit)

-$367,545,000 (-12.73%)

-$326,026,000 (-22.41%)

-$266,341,000 (-28.08%)

-$207,953,000 (-27.21%)

Tax Assets

$901,000 (40.12%)

$643,000 (94.26%)

$331,000 (-7.02%)

$356,000 (-50.90%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$54,797,000 (5.84%)

$51,775,000 (1978.48%)

$2,491,000 (256.88%)

$698,000 (-25.82%)

Debt Current

$571,000 (4.58%)

$546,000 (10.30%)

$495,000 (120.98%)

$224,000 (-8.57%)

Debt Non-Current

$54,226,000 (5.85%)

$51,229,000 (2466.58%)

$1,996,000 (321.10%)

$474,000 (-31.90%)

Total Liabilities

$62,352,000 (6.67%)

$58,455,000 (618.56%)

$8,135,000 (12.22%)

$7,249,000 (5.75%)

Liabilities Current

$8,126,000 (12.46%)

$7,226,000 (17.71%)

$6,139,000 (-9.39%)

$6,775,000 (10.00%)

Liabilities Non-Current

$54,226,000 (5.85%)

$51,229,000 (2466.58%)

$1,996,000 (321.10%)

$474,000 (-31.90%)

MIST Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$1,000,000 (-80.00%)

$5,000,000 (-66.67%)

$15,000,000 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$16,742,000 (5.08%)

$15,932,000 (1.36%)

$15,718,000 (26.77%)

$12,399,000 (20.55%)

Research & Development Expense

$14,357,000 (-53.76%)

$31,052,000 (-22.04%)

$39,829,000 (2.99%)

$38,671,000 (12.13%)

Operating Expenses

$42,102,000 (-32.20%)

$62,098,000 (-3.94%)

$64,642,000 (11.31%)

$58,073,000 (14.52%)

Interest Expense

$3,581,000 (40.21%)

$2,554,000 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$41,519,000 (30.44%)

-$59,685,000 (-2.22%)

-$58,388,000 (-36.25%)

-$42,853,000 (14.24%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$41,519,000 (30.44%)

-$59,685,000 (-2.22%)

-$58,388,000 (-36.25%)

-$42,853,000 (14.24%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$41,519,000 (30.44%)

-$59,685,000 (-2.22%)

-$58,388,000 (-36.25%)

-$42,853,000 (14.24%)

Weighted Average Shares

$62,210,702 (44.82%)

$42,955,779 (1.19%)

$42,450,316 (1.47%)

$41,833,861 (42.56%)

Weighted Average Shares Diluted

$62,210,702 (44.82%)

$42,955,779 (1.19%)

$42,450,316 (1.47%)

$41,833,861 (42.56%)

Earning Before Interest & Taxes (EBIT)

-$37,938,000 (33.59%)

-$57,131,000 (2.15%)

-$58,388,000 (-36.25%)

-$42,853,000 (14.27%)

Gross Profit

$0 (0%)

$1,000,000 (-80.00%)

$5,000,000 (-66.67%)

$15,000,000 (0%)

Operating Income

-$42,102,000 (31.09%)

-$61,098,000 (-2.44%)

-$59,642,000 (-38.47%)

-$43,073,000 (15.06%)

MIST Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$8,283,000 (74.16%)

$4,756,000 (108.33%)

-$57,124,000 (-181.61%)

$70,000,000 (200.00%)

Net Cash Flow from Financing

$32,119,000 (-32.79%)

$47,792,000 (1447.67%)

$3,088,000 (-38.91%)

$5,055,000 (-93.10%)

Net Cash Flow from Operations

-$28,848,000 (37.86%)

-$46,424,000 (11.52%)

-$52,469,000 (-57.92%)

-$33,224,000 (34.51%)

Net Cash Flow / Change in Cash & Cash Equivalents

$11,554,000 (88.67%)

$6,124,000 (105.75%)

-$106,505,000 (-354.61%)

$41,831,000 (188.05%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$8,316,000 (70.83%)

$4,868,000 (108.56%)

-$56,852,000 (-181.22%)

$70,000,000 (200.00%)

Capital Expenditure

-$33,000 (70.54%)

-$112,000 (58.82%)

-$272,000 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$47,218,000 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$32,119,000 (5418.73%)

$582,000 (-81.15%)

$3,088,000 (2452.07%)

$121,000 (-99.83%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$5,776,000 (-39.42%)

$9,534,000 (5.37%)

$9,048,000 (24.30%)

$7,279,000 (47.20%)

Depreciation Amortization & Accretion

$105,000 (14.13%)

$92,000 (3.37%)

$89,000 (-4.30%)

$93,000 (-4.12%)

MIST Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

100.00% (0.00%)

100.00% (0.00%)

100.00%

Profit Margin

-

-5968.50% (-411.09%)

-1167.80% (-308.75%)

-285.70%

EBITDA Margin

-

-5703.90% (-389.19%)

-1166.00% (-308.98%)

-285.10%

Return on Average Equity (ROAE)

-152.30% (10.94%)

-171.00% (-142.21%)

-70.60% (-110.75%)

-33.50% (27.49%)

Return on Average Assets (ROAA)

-48.40% (24.84%)

-64.40% (1.53%)

-65.40% (-105.02%)

-31.90% (27.00%)

Return on Sales (ROS)

-

-5713.10% (-389.22%)

-1167.80% (-308.75%)

-285.70%

Return on Invested Capital (ROIC)

-32.00% (42.13%)

-55.30% (66.44%)

-164.80% (-17.05%)

-140.80% (-14.56%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-3.52 (-193.26%)

-1.2 (58.15%)

-2.87 (55.31%)

-6.42 (-62.95%)

Price to Sales Ratio (P/S)

-

71.74 (113.37%)

33.62 (84.05%)

18.27

Price to Book Ratio (P/B)

9.57 (187.13%)

3.33 (62.95%)

2.05 (17.72%)

1.74 (24.50%)

Debt to Equity Ratio (D/E)

4.74 (36.10%)

3.48 (2733.33%)

0.12 (92.19%)

0.06 (33.33%)

Earnings Per Share (EPS)

-0.67 (51.80%)

-1.39 (-0.72%)

-1.38 (-35.29%)

-1.02 (40.00%)

Sales Per Share (SPS)

0 (0%)

0.02 (-80.51%)

0.12 (-67.13%)

0.36 (0%)

Free Cash Flow Per Share (FCFPS)

-0.46 (57.16%)

-1.08 (12.80%)

-1.24 (-56.42%)

-0.79 (54.08%)

Book Value Per Share (BVPS)

0.21 (-45.90%)

0.39 (-75.05%)

1.56 (-41.94%)

2.69 (-44.80%)

Tangible Assets Book Value Per Share (TABVPS)

1.21 (-30.67%)

1.75 (-0.23%)

1.75 (-38.74%)

2.87 (-43.94%)

Enterprise Value Over EBIT (EV/EBIT)

-4 (-100.00%)

-2 (0.00%)

-2 (0.00%)

-2 (33.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

-4.42 (-159.46%)

-1.7 (1.85%)

-1.73 (12.78%)

-1.99 (35.54%)

Asset Turnover

0 (0%)

0.01 (-80.36%)

0.06 (-50.00%)

0.11 (0%)

Current Ratio

9.1 (-9.99%)

10.11 (-13.59%)

11.7 (-33.37%)

17.55 (-27.29%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$28,881,000 (37.94%)

-$46,536,000 (11.77%)

-$52,741,000 (-58.74%)

-$33,224,000 (34.51%)

Enterprise Value (EV)

$167,072,863 (72.12%)

$97,065,795 (-3.96%)

$101,065,568 (18.89%)

$85,005,104 (-44.75%)

Earnings Before Tax (EBT)

-$41,519,000 (30.44%)

-$59,685,000 (-2.22%)

-$58,388,000 (-36.25%)

-$42,853,000 (14.27%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$37,833,000 (33.67%)

-$57,039,000 (2.16%)

-$58,299,000 (-36.34%)

-$42,760,000 (14.29%)

Invested Capital

$96,856,000 (-8.64%)

$106,015,000 (67.75%)

$63,199,000 (17227.10%)

-$369,000 (-100.51%)

Working Capital

$65,800,000 (-0.01%)

$65,806,000 (0.22%)

$65,664,000 (-41.45%)

$112,148,000 (-21.31%)

Tangible Asset Value

$75,499,000 (0.36%)

$75,226,000 (1.00%)

$74,483,000 (-37.85%)

$119,849,000 (-20.09%)

Market Capitalization

$125,853,863 (125.07%)

$55,916,795 (-58.82%)

$135,772,568 (-30.61%)

$195,665,104 (-2.08%)

Average Equity

$27,264,500 (-21.89%)

$34,904,500 (-57.81%)

$82,729,500 (-35.32%)

$127,900,750 (18.16%)

Average Assets

$85,859,500 (-7.29%)

$92,610,250 (3.66%)

$89,337,500 (-33.52%)

$134,390,750 (17.61%)

Invested Capital Average

$118,606,250 (14.88%)

$103,240,500 (191.48%)

$35,419,250 (16.36%)

$30,440,000 (-25.18%)

Shares

53,327,908 (59.27%)

33,483,111 (-2.34%)

34,286,002 (14.77%)

29,872,535 (0.17%)